JPS56135419A - Preventive and improver for radiation disorder - Google Patents

Preventive and improver for radiation disorder

Info

Publication number
JPS56135419A
JPS56135419A JP3823580A JP3823580A JPS56135419A JP S56135419 A JPS56135419 A JP S56135419A JP 3823580 A JP3823580 A JP 3823580A JP 3823580 A JP3823580 A JP 3823580A JP S56135419 A JPS56135419 A JP S56135419A
Authority
JP
Japan
Prior art keywords
bacterium
oligosaccharides
improver
preventive
gal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3823580A
Other languages
Japanese (ja)
Other versions
JPS6241569B2 (en
Inventor
Masahiko Mutai
Teruo Yokokura
Masaharu Onoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Priority to JP3823580A priority Critical patent/JPS56135419A/en
Publication of JPS56135419A publication Critical patent/JPS56135419A/en
Publication of JPS6241569B2 publication Critical patent/JPS6241569B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

PURPOSE: A preventive and improver for disorders occurring during irradiation for remedying malignant tumor, etc., comprising a bacterium belonging to the genus bifidobacterium and factors for promoting its propagation as active ingredients.
CONSTITUTION: The titled preventive and improver comprising a bacterium belonging to the genus Bifidobacterium [e.g., bifidobacterium (a bacterium derived from babies of human breast milk nutrition), Lactobacillus acidophilus (derived from human and bacterium occurring fixedly in mouse)], a kind of bacterium existing always in the intestines, and oligosaccharides (namely, oligosaccharides obtained by treating lactose with β-glactosidase, usually a mixture of oligosaccharides) shown by the formula Gal-(Gal)m-Glc(Gal is galactose residue; Glc is glucose residue; n is 1-4) as active ingredients. When the bacterium of the genus Bifidobacterium is blended with the abovementioned oligosaccharides, factors for promoting its propagation and it is propagated specifically in the intestines, disorders caused by irradiation to digestive tubes for remedying malignant tumor, etc. are prevented and improved.
COPYRIGHT: (C)1981,JPO&Japio
JP3823580A 1980-03-27 1980-03-27 Preventive and improver for radiation disorder Granted JPS56135419A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3823580A JPS56135419A (en) 1980-03-27 1980-03-27 Preventive and improver for radiation disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3823580A JPS56135419A (en) 1980-03-27 1980-03-27 Preventive and improver for radiation disorder

Publications (2)

Publication Number Publication Date
JPS56135419A true JPS56135419A (en) 1981-10-22
JPS6241569B2 JPS6241569B2 (en) 1987-09-03

Family

ID=12519630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3823580A Granted JPS56135419A (en) 1980-03-27 1980-03-27 Preventive and improver for radiation disorder

Country Status (1)

Country Link
JP (1) JPS56135419A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100330054A1 (en) * 2007-10-11 2010-12-30 Fayrefield Foods Limited Preparation, use of preparation for treatment, and method of treatment of intestinal infection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100330054A1 (en) * 2007-10-11 2010-12-30 Fayrefield Foods Limited Preparation, use of preparation for treatment, and method of treatment of intestinal infection

Also Published As

Publication number Publication date
JPS6241569B2 (en) 1987-09-03

Similar Documents

Publication Publication Date Title
Riggio et al. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients
Terada et al. Effect of lactulose on the composition and metabolic activity of the human faecal flora
CA2099855C (en) Antigastritis agent
Sanders Lactic acid bacteria as promoters of human health
Bolognani et al. Influence of carcinogen binding by lactic acid-producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens
Kolida et al. Prebiotic effects of inulin and oligofructose
TWI491732B (en) Equol-containing fermented soybean hypocotyl and method of producing the same
Bolognani et al. Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats
EP1112692B1 (en) Drinks and foods capable of eliminating helicobacter pylori
Voorhess et al. URINARY EXCRETION OF NOREPINEPHRINE, EPINEPHRINE AND 3-METHOXY-4-HYDROXYMANDELIC ACID BY CHILDREN WITH NEURO-BLASTOMA
Taper et al. Possible adjuvant cancer therapy by two prebiotics-inulin or oligofructose
Cole et al. Effect of probiotic supplements of lactobacillus acidophilus and Bifidobacterium adolescentis 2204 on β-glueosidase and β-glueuronidase activity in the lower gut of rats associated with a human faecal flora
BRPI0206689B1 (en) composition of probiotics and use of this
Yamazaki et al. The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat.
Parodi The role of intestinal bacteria in the causation and prevention of cancer: modulation by diet and probiotics
PT1649760E (en) Composition containing lactic acid bacterium producing equol
Adachi Lactic acid bacteria and the control of tumours
WO1999017788A1 (en) Composition of treatment of candidiasis
Shen et al. Immunomopharmacological effects of polysaccharides from Acanthopanax senticosus on experimental animals
Apgar et al. The effect of feeding various levels of Bifidobacterium globosum A on the performance, gastrointestinal measurements, and immunity of weanling pigs and on the performance and carcass measurements of growing-finishing pigs
Herich et al. The effect of Lactobacillus paracasei and Raftilose P95 upon the non-specific immune response of piglets
JPS56135419A (en) Preventive and improver for radiation disorder
WO2002045727A1 (en) Lactic acid bacteria inhibiting adhesion of helicobacter pylori to gastric mucosa
Vanderhoof et al. The role of probiotics in the treatment of intestinal infections and inflammation
Visek Dietary protein and experimental carcinogenesis